HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glutathione S transferase M1 and T1 genetic polymorphisms are related to the risk of primary open-angle glaucoma: a study in a Turkish population.

AbstractBACKGROUND:
Genetic factors and oxidative damage have been shown to have a role in the development of primary open angle glaucoma (POAG).
AIM:
To determine the effects of genetic polymorphisms of glutathione S transferase (GST)M1 and GSTT1 on the risk of POAG in a Turkish population.
METHODS:
Using a multiplex polymerase chain reaction (PCR), GSTM1 and GSTT1 gene polymorphisms were analysed in 144 patients with POAG and in 121 otherwise healthy controls of similar age.
RESULTS:
The GSTM1 positive genotype and the GSTT1 null genotype had an increased risk of developing POAG (p<0.001, OR 2.93, 95% CI 1.66 to 5.20 and OR 4.25, 95% CI 2.30 to 7.80, respectively). The risk of glaucoma also increased significantly in subjects with a combination of GSTM1 positive and GSTT1 null genotypes (p<0.001, OR 3.46, 95% CI 1.64 to 7.38).
CONCLUSION:
The GSTM1 positive genotype and GSTT1 null genotype or the combination of both may be associated with the increased risk of development of POAG in the Turkish population.
AuthorsMustafa Unal, Mehmet Güven, Kazim Devranoğlu, Ahmet Ozaydin, Bahadir Batar, Nevbahar Tamçelik, Ebru Eroğlu Görgün, Didar Uçar, Ahmet Sarici
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 91 Issue 4 Pg. 527-30 (Apr 2007) ISSN: 0007-1161 [Print] England
PMID16973661 (Publication Type: Journal Article)
Chemical References
  • glutathione S-transferase T1
  • Glutathione Transferase
  • glutathione S-transferase M1
Topics
  • Aged
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Glaucoma, Open-Angle (genetics)
  • Glutathione Transferase (genetics)
  • Humans
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Polymorphism, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: